Industries

Microbiome Research and Therapeutics

Microbiome therapeutics target the trillions of microorganisms colonizing the human gut, skin, and other niches to treat metabolic, inflammatory, and neurological conditions. The industry recruits metagenomics PhDs and licenses gnotobiotic mouse model platforms and strain collections from academic microbiome centers.

Details

Companies

Seres TherapeuticsVedanta BiosciencesSynlogicEvivo Evolve BioSystemsBiomXKaleido BiosciencesAssembly BiosciencesHolobiomeProlacta Bioscience4D Medical

Market Size

$2.3B

Target Researchers

Microbiologists, gastrointestinal biologists, and metagenomicists specializing in gut, oral, and skin microbiome characterization, microbial ecology, gnotobiotic animal models, and live biotherapeutic manufacturing

Use Cases

Microbial strain library licensingGnotobiotic model collaborationMetagenomic profiling partnershipsMicrobial metabolite biomarker developmentFMT protocol consultingLive biotherapeutic manufacturing scale-up